Efficacy of vibegron, a novel β3‐adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo‐controlled, double‐blind, comparative phase 3 study

OBJECTIVE: To evaluate the efficacy of a novel and selective β3‐adrenoreceptor agonist vibegron on urgency urinary incontinence (UUI) in patients with overactive bladder (OAB). PATIENTS AND METHODS: A post hoc analysis was performed in patients with UUI (>0 episodes/day) who were assigned to rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Masaki, Takeda, Masayuki, Gotoh, Momokazu, Yokoyama, Osamu, Kakizaki, Hidehiro, Takahashi, Satoru, Masumori, Naoya, Nagai, Shinji, Minemura, Kazuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Functional Urology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318146/
https://www.ncbi.nlm.nih.gov/pubmed/31991511
http://dx.doi.org/10.1111/bju.15020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318146/
https://www.ncbi.nlm.nih.gov/pubmed/31991511
http://dx.doi.org/10.1111/bju.15020

Ejemplares similares